Bayer backs Iberogast against safety attacks

Bayer Consumer Health has defended its decision not to include warnings about possible liver-damage when taking its herbal gastrointestinal product Iberogast, after harsh criticism from German Member of Parliament (MP) Kordula Schulz-Asche.

More from Regulation

More from Policy & Regulation